{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:24:02Z","timestamp":1791307442058,"version":"4.3.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-86926-8","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T13:11:57Z","timestamp":1738588317000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Using computer modeling to find new LRRK2 inhibitors for parkinson\u2019s disease"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5283-5337","authenticated-orcid":false,"given":"Mar\u00eda C.","family":"Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8035-6220","authenticated-orcid":false,"given":"Sebasti\u00e1n A.","family":"Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6128-9504","authenticated-orcid":false,"given":"Jos\u00e9 R.","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6177-7919","authenticated-orcid":false,"given":"Jose L.","family":"Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2721-1142","authenticated-orcid":false,"given":"Yovani","family":"Marrero-Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Alexis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7503-1528","authenticated-orcid":false,"given":"Edgar A.","family":"M\u00e1rquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"86926_CR1","unstructured":"Parkinson\u2019s Foundation, U. S. A. (2023). https:\/\/www.parkinson.org\/understanding-parkinsons\/causes. Accessed 9 Sep 2024."},{"key":"86926_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom11060897","volume":"11","author":"O Kosz\u0142a","year":"2021","unstructured":"Kosz\u0142a, O. et al. Current approaches and tools used in drug development against parkinson\u2019s disease. Biomolecules 11, 1\u201316. https:\/\/doi.org\/10.3390\/biom11060897 (2021).","journal-title":"Biomolecules"},{"key":"86926_CR3","doi-asserted-by":"publisher","unstructured":"Schapira, A. H. V., Bezard, E., Brotchie, J. & Calon, F. Novel pharmacological targets for the treatment of Parkinson \u2019 s disease. 5:845\u2013854. (2006). https:\/\/doi.org\/10.1038\/nrd2087","DOI":"10.1038\/nrd2087"},{"key":"86926_CR4","doi-asserted-by":"publisher","unstructured":"Loza, M. I. & Carlsson, J. Docking screens for dual inhibitors of Disparate Drug targets for Parkinson \u2019 s Disease. (2018). https:\/\/doi.org\/10.1021\/acs.jmedchem.8b00204","DOI":"10.1021\/acs.jmedchem.8b00204"},{"key":"86926_CR5","doi-asserted-by":"publisher","unstructured":"Meissner, W. G. et al. Priorities in Parkinson \u2019 s disease research. 10:. (2011). https:\/\/doi.org\/10.1038\/nrd3430","DOI":"10.1038\/nrd3430"},{"key":"86926_CR6","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.bmcl.2018.11.058","volume":"29","author":"J Osborne","year":"2018","unstructured":"Osborne, J. et al. Discovery of potent and selective 5-azaindazole inhibitors of leucine-rich repeat kinase 2 (LRRK2) \u2013 part 1. Bioorg. Med. Chem. Lett. 29, 668\u2013673. https:\/\/doi.org\/10.1016\/j.bmcl.2018.11.058 (2018).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"86926_CR7","doi-asserted-by":"publisher","unstructured":"Cruz-Vicente, P., Passarinha, L. A., Silvestre, S. & Gallardo, E. Recent developments in new therapeutic agents against alzheimer and parkinson diseases: In-silico approaches. Molecules 26 https:\/\/doi.org\/10.3390\/molecules26082193 (2021).","DOI":"10.3390\/molecules26082193"},{"key":"86926_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.compbiolchem.2019.01.012","volume":"79","author":"N Agrawal","year":"2019","unstructured":"Agrawal, N. & Mishra, P. Synthesis, monoamine oxidase inhibitory activity and computational study of novel isoxazole derivatives as potential antiparkinson agents. Comput. Biol. Chem. 79, 63\u201372. https:\/\/doi.org\/10.1016\/j.compbiolchem.2019.01.012 (2019).","journal-title":"Comput. Biol. Chem."},{"key":"86926_CR9","doi-asserted-by":"publisher","first-page":"135222","DOI":"10.1016\/j.neulet.2020.135222","volume":"735","author":"A Masih","year":"2020","unstructured":"Masih, A. et al. Design and development of 1,3,5-triazine-thiadiazole hybrids as potent adenosine A2A receptor (A2AR) antagonist for benefit in Parkinson\u2019s disease. Neurosci. Lett. 735, 135222. https:\/\/doi.org\/10.1016\/j.neulet.2020.135222 (2020).","journal-title":"Neurosci. Lett."},{"key":"86926_CR10","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1055\/a-0808-3993","volume":"69","author":"HDJ Van Rensburg","year":"2019","unstructured":"Van Rensburg, H. D. J., Legoabe, L. J., Terre\u2019Blanche, G. & Van Der Walt, M. M. 2-Benzylidene-1-Indanone analogues as dual Adenosine A 1 \/A 2a receptor antagonists for the potential treatment of neurological conditions. Drug Res. 69, 382\u2013391. https:\/\/doi.org\/10.1055\/a-0808-3993 (2019).","journal-title":"Drug Res."},{"key":"86926_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1055\/a-1146-2996","volume":"70","author":"HD Van Janse","year":"2020","unstructured":"Van Janse, H. D., Legoabe, L. J. & Terre\u2019Blanche, G. Synthesis and structure Activity relationships of Chalcone based Benzocycloalkanone Derivatives as Adenosine A 1 and\/or a 2A receptor antagonists. Drug Res. 70, 243\u2013256. https:\/\/doi.org\/10.1055\/a-1146-2996 (2020).","journal-title":"Drug Res."},{"key":"86926_CR12","doi-asserted-by":"publisher","first-page":"112305","DOI":"10.1016\/j.jep.2019.112305","volume":"248","author":"D Naidoo","year":"2020","unstructured":"Naidoo, D. et al. New role for crinamine as a potent, safe and selective inhibitor of human monoamine oxidase B: in vitro and in silico pharmacology and modeling. J. Ethnopharmacol. 248, 112305. https:\/\/doi.org\/10.1016\/j.jep.2019.112305 (2020).","journal-title":"J. Ethnopharmacol."},{"key":"86926_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules24040810","volume":"24","author":"ND Chaurasiya","year":"2019","unstructured":"Chaurasiya, N. D. et al. Selective inhibition of human monoamine oxidase B by Acacetin 7-Methyl ether isolated from Turnera diffusa (Damiana). Molecules 24, 1\u201315. https:\/\/doi.org\/10.3390\/molecules24040810 (2019).","journal-title":"Molecules"},{"key":"86926_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules25112678","volume":"25","author":"E Kozio\u0142","year":"2020","unstructured":"Kozio\u0142, E. et al. Rutamarin: efficient liquid\u2013liquid chromatographic isolation from ruta graveolens L. and evaluation of its in vitro and in silico MAO-B inhibitory activity. Molecules 25, 1\u201312. https:\/\/doi.org\/10.3390\/molecules25112678 (2020).","journal-title":"Molecules"},{"key":"86926_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.34049\/bcc.52.A.330","volume":"52","author":"AZ Rizakov","year":"2020","unstructured":"Rizakov, A. Z., Kolev, M. K. & Velkov, Z. A. QSAR analysis of coumarins, flavones and their bicyclo ethers as monoamine oxidases inhibitors. Bul. Chem. Commun. 52, 93\u2013100. https:\/\/doi.org\/10.34049\/bcc.52.A.330 (2020).","journal-title":"Bul. Chem. Commun."},{"key":"86926_CR16","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1080\/14756366.2019.1571272","volume":"34","author":"D Secci","year":"2019","unstructured":"Secci, D. et al. 4-(3-Nitrophenyl)thiazol-2-ylhydrazone derivatives as antioxidants and selective hMAO-B inhibitors: synthesis, biological activity and computational analysis. J. Enzyme Inhib. Med. Chem. 34, 597\u2013612. https:\/\/doi.org\/10.1080\/14756366.2019.1571272 (2019).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"86926_CR17","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1021\/acschemneuro.7b00050","volume":"8","author":"MH Nam","year":"2017","unstructured":"Nam, M. H. et al. Indole-substituted benzothiazoles and Benzoxazoles as selective and reversible MAO-B inhibitors for treatment of Parkinson\u2019s Disease. ACS Chem. Neurosci. 8, 1519\u20131529. https:\/\/doi.org\/10.1021\/acschemneuro.7b00050 (2017).","journal-title":"ACS Chem. Neurosci."},{"key":"86926_CR18","doi-asserted-by":"publisher","first-page":"15021","DOI":"10.1021\/acs.jmedchem.0c01663","volume":"63","author":"CF Jin","year":"2020","unstructured":"Jin, C. F. et al. Computational fragment-based design facilitates Discovery of Potent and Selective Monoamine Oxidase-B (MAO-B) inhibitor. J. Med. Chem. 63, 15021\u201315036. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01663 (2020).","journal-title":"J. Med. Chem."},{"key":"86926_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13065-019-0552-4","volume":"13","author":"P Dhiman","year":"2019","unstructured":"Dhiman, P., Malik, N. & Khatkar, A. Lead optimization for promising monoamine oxidase inhibitor from eugenol for the treatment of neurological disorder: synthesis and in silico based study. BMC Chem. 13, 1\u201320. https:\/\/doi.org\/10.1186\/s13065-019-0552-4 (2019).","journal-title":"BMC Chem."},{"key":"86926_CR20","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1080\/07391102.2020.1824815","volume":"40","author":"S Khamouli","year":"2020","unstructured":"Khamouli, S. et al. Multi-combined 3D-QSAR, docking molecular and ADMET prediction of 5-azaindazole derivatives as LRRK2 tyrosine kinase inhibitors. J. Biomol. Struct. Dyn. 40, 1285\u20131298. https:\/\/doi.org\/10.1080\/07391102.2020.1824815 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"86926_CR21","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ejmech.2017.06.060","volume":"138","author":"IG Salado","year":"2017","unstructured":"Salado, I. G. et al. Leucine rich repeat kinase 2 (LRRK2) inhibitors based on indolinone scaffold: potential pro-neurogenic agents. Eur. J. Med. Chem. 138, 328\u2013342. https:\/\/doi.org\/10.1016\/j.ejmech.2017.06.060 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"86926_CR22","doi-asserted-by":"publisher","unstructured":"Cabrera, N. et al. In Silico Searching for alternative lead compounds to treat type 2 diabetes through a QSAR and Molecular Dynamics Study. Pharmaceutics 14 https:\/\/doi.org\/10.3390\/pharmaceutics14020232 (2022).","DOI":"10.3390\/pharmaceutics14020232"},{"key":"86926_CR23","doi-asserted-by":"publisher","unstructured":"Cabrera, N. et al. Searching glycolate oxidase inhibitors based on QSAR, molecular docking, and molecular dynamic simulation approaches. Sci. Rep. 12, 1\u201319. https:\/\/doi.org\/10.1038\/s41598-022-24196-4 (2022).","DOI":"10.1038\/s41598-022-24196-4"},{"key":"86926_CR24","doi-asserted-by":"publisher","unstructured":"Valencia, J. et al. QSAR Studies, Molecular Docking, Molecular Dynamics, Synthesis, and Biological evaluation of Novel Quinolinone-based thiosemicarbazones against Mycobacterium tuberculosis. Antibiotics 12 https:\/\/doi.org\/10.3390\/antibiotics12010061 (2023).","DOI":"10.3390\/antibiotics12010061"},{"key":"86926_CR25","doi-asserted-by":"publisher","unstructured":"Mora, J. R. & Marrero-ponce, Y. Ensemble models based on QuBiLS-MAS features and shallow learning for the Prediction of Drug-Induced Liver toxicity: improving Deep Learning and Traditional Approaches \u0301. (2020). https:\/\/doi.org\/10.1021\/acs.chemrestox.0c00030","DOI":"10.1021\/acs.chemrestox.0c00030"},{"key":"86926_CR26","doi-asserted-by":"publisher","unstructured":"Cuesta, S. A., Mora, J. R. & M\u00e1rquez, E. A. In silico screening of the drugbank database to search for possible drugs against sars-cov-2. Molecules 26 https:\/\/doi.org\/10.3390\/molecules26041100 (2021).","DOI":"10.3390\/molecules26041100"},{"key":"86926_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ijbiomac.2022.09.151","volume":"222","author":"T Sharma","year":"2022","unstructured":"Sharma, T. et al. Combining structure-based pharmacophore modeling and machine learning for the identification of novel BTK inhibitors. Int. J. Biol. Macromol. 222, 239\u2013250. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.09.151 (2022).","journal-title":"Int. J. Biol. Macromol."},{"key":"86926_CR28","doi-asserted-by":"publisher","unstructured":"Siddiqui, A. J. et al. Targeting Monoamine Oxidase B for the treatment of Alzheimer\u2019s and Parkinson\u2019s diseases using novel inhibitors identified using an Integrated Approach of Machine Learning and computer-aided Drug Design. Mathematics 11 https:\/\/doi.org\/10.3390\/math11061464 (2023).","DOI":"10.3390\/math11061464"},{"key":"86926_CR29","doi-asserted-by":"publisher","first-page":"e0306579","DOI":"10.1371\/journal.pone.0306579","volume":"19","author":"AJ Siddiqui","year":"2024","unstructured":"Siddiqui, A. J. et al. A computational and machine learning approach to identify GPR40-targeting agonists for neurodegenerative disease treatment. PLoS One. 19, e0306579. https:\/\/doi.org\/10.1371\/journal.pone.0306579 (2024).","journal-title":"PLoS One"},{"key":"86926_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1145\/1656274.1656278","volume":"11","author":"M Hall","year":"2009","unstructured":"Hall, M. et al. The WEKA data mining software: an update. SIGKDD Explor. 11, 10 (2009).","journal-title":"SIGKDD Explor."},{"key":"86926_CR31","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/minf.201000061","volume":"29","author":"A Tropsha","year":"2010","unstructured":"Tropsha, A. Best practices for QSAR model development, validation, and exploitation. Mol. Inf. 29, 476\u2013488. https:\/\/doi.org\/10.1002\/minf.201000061 (2010).","journal-title":"Mol. Inf."},{"key":"86926_CR32","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart, D. S. et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 46, D1074\u2013D1082. https:\/\/doi.org\/10.1093\/nar\/gkx1037 (2018).","journal-title":"Nucleic Acids Res."},{"key":"86926_CR33","unstructured":"Schrodinger, L. The PyMOL molecular graphics system, version 1.3r1 (2010)."},{"key":"86926_CR34","unstructured":"Version, A. et al. AutoDock Version 4.2. 1\u201369 (2014)."},{"key":"86926_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-5-367","volume-title":"ACPYPE-AnteChamber PYthon Parser interfacE","author":"AW Sousa da Silva","year":"2012","unstructured":"Sousa da Silva, A. W. & Vranken, W. F. ACPYPE-AnteChamber PYthon Parser interfacE (In: BMC Res Notes, 2012)."},{"key":"86926_CR36","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1002\/prot.22711","volume":"78","author":"K Lindorff-Larsen","year":"2010","unstructured":"Lindorff-Larsen, K. & Al, E. Improved side-chain torsion potentials for the Amber ff99SB protein force field: improved protein sidechain potentials. Proteins 78, 1950\u20131958. https:\/\/doi.org\/10.1002\/prot.22711 (2010).","journal-title":"Proteins"},{"key":"86926_CR37","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1063\/1.448118","volume":"81","author":"HJC Berendsen","year":"1984","unstructured":"Berendsen, H. J. C. et al. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81, 3684\u20133690. https:\/\/doi.org\/10.1063\/1.448118 (1984).","journal-title":"J. Chem. Phys."},{"key":"86926_CR38","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel, D. et al. GROMACS: fast, flexible, and free. J. Comput. Chem. 26, 1701\u20131718. https:\/\/doi.org\/10.1002\/jcc.20291 (2005).","journal-title":"J. Comput. Chem."},{"key":"86926_CR39","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1016\/j.bmcl.2013.05.054","volume":"23","author":"T Troxler","year":"2013","unstructured":"Troxler, T. et al. Discovery of novel indolinone-based, potent, selective and brain penetrant inhibitors of LRRK2. Bioorg. Med. Chem. Lett. 23, 4085\u20134090. https:\/\/doi.org\/10.1016\/j.bmcl.2013.05.054 (2013).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"86926_CR40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1093-3263(01)00123-1","volume":"20","author":"A Golbraikh","year":"2002","unstructured":"Golbraikh, A. & Tropsha, A. Beware of q2! J. Mol. Graph Model. 20, 269\u2013276. https:\/\/doi.org\/10.1016\/S1093-3263(01)00123-1 (2002).","journal-title":"J. Mol. Graph Model."},{"key":"86926_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41564-019-0639-7","volume":"5","author":"KA Kormuth","year":"2020","unstructured":"Kormuth, K. A. & Lakdawala, S. S. Emerging antiviral resistance. Nat. Microbiol. 5, 4\u20135. https:\/\/doi.org\/10.1038\/s41564-019-0639-7 (2020).","journal-title":"Nat. Microbiol."},{"key":"86926_CR42","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJ Murray","year":"2022","unstructured":"Murray, C. J. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629\u2013655. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0 (2022).","journal-title":"Lancet"},{"key":"86926_CR43","unstructured":"National Center for Biotechnology Information. PubChem Compound Summary for CID 5546, Triamterene. (2023). https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Triamterene. Accessed 24 Apr 2023."},{"key":"86926_CR44","unstructured":"National Center for Biotechnology Information. PubChem Compound Summary for CID 4756, Phenazopyridine. (2023). https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Phenazopyridine. Accessed 24 Apr 2023."},{"key":"86926_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41421-023-00639-8","volume":"10","author":"H Zhu","year":"2024","unstructured":"Zhu, H., Hixson, P., Ma, W. & Sun, J. Pharmacology of LRRK2 with type I and II kinase inhibitors revealed by cryo-EM. Cell. Discov. 10, 10. https:\/\/doi.org\/10.1038\/s41421-023-00639-8 (2024).","journal-title":"Cell. Discov"},{"key":"86926_CR46","doi-asserted-by":"publisher","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7 https:\/\/doi.org\/10.1038\/srep42717 (2017).","DOI":"10.1038\/srep42717"},{"key":"86926_CR47","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1021\/ci034243x","volume":"44","author":"JS Delaney","year":"2004","unstructured":"Delaney, J. S. ESOL: estimating aqueous solubility directly from molecular structure. J. Chem. Inf. Comput. Sci. 44, 1000\u20131005. https:\/\/doi.org\/10.1021\/ci034243x (2004).","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"86926_CR48","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1021\/ci200387c","volume":"52","author":"J Ali","year":"2012","unstructured":"Ali, J. et al. Revisiting the general solubility equation: in silico prediction of aqueous solubility incorporating the effect of topographical polar surface area. J. Chem. Inf. Model. 52, 420\u2013428. https:\/\/doi.org\/10.1021\/ci200387c (2012).","journal-title":"J. Chem. Inf. Model."},{"key":"86926_CR49","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0022-2836(84)90309-7","volume":"179","author":"D Eisenberg","year":"1984","unstructured":"Eisenberg, D., Schwarz, E., Komaromy, M. & Wall, R. Analysis of membrane and surface protein sequences with the hydrophobic moment plot. J. Mol. Biol. 179, 125\u2013142. https:\/\/doi.org\/10.1016\/0022-2836(84)90309-7 (1984).","journal-title":"J. Mol. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86926-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86926-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86926-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T13:12:02Z","timestamp":1738588322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86926-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["86926"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-86926-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"20 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4085"}}